174 related articles for article (PubMed ID: 32153365)
1. Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model.
Zhong X; Harris G; Smirnova L; Zufferey V; Sá RCDSE; Baldino Russo F; Baleeiro Beltrao Braga PC; Chesnut M; Zurich MG; Hogberg HT; Hartung T; Pamies D
Front Cell Neurosci; 2020; 14():25. PubMed ID: 32153365
[TBL] [Abstract][Full Text] [Related]
2. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
[TBL] [Abstract][Full Text] [Related]
3. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity.
Ryan KR; Sirenko O; Parham F; Hsieh JH; Cromwell EF; Tice RR; Behl M
Neurotoxicology; 2016 Mar; 53():271-281. PubMed ID: 26854185
[TBL] [Abstract][Full Text] [Related]
4. Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.
Koch K; Bartmann K; Hartmann J; Kapr J; Klose J; Kuchovská E; Pahl M; Schlüppmann K; Zühr E; Fritsche E
Front Toxicol; 2022; 4():816370. PubMed ID: 35295221
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
6. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.
Peng SP; Schachner M; Boddeke E; Copray S
Cell Reprogram; 2016 Apr; 18(2):55-66. PubMed ID: 26990843
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.
Gil-Ad I; Zolokov A; Lomnitski L; Taler M; Bar M; Luria D; Ram E; Weizman A
Int J Oncol; 2008 Aug; 33(2):277-86. PubMed ID: 18636148
[TBL] [Abstract][Full Text] [Related]
9. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
Schmuck MR; Temme T; Dach K; de Boer D; Barenys M; Bendt F; Mosig A; Fritsche E
Arch Toxicol; 2017 Apr; 91(4):2017-2028. PubMed ID: 27722930
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine use during pregnancy: is it safe?
Thormahlen GM
Ann Pharmacother; 2006 Oct; 40(10):1834-7. PubMed ID: 16926304
[TBL] [Abstract][Full Text] [Related]
11. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review.
Jing E; Straw-Wilson K
Ment Health Clin; 2016 Jul; 6(4):191-196. PubMed ID: 29955469
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
13. Microglia Increase Inflammatory Responses in iPSC-Derived Human BrainSpheres.
Abreu CM; Gama L; Krasemann S; Chesnut M; Odwin-Dacosta S; Hogberg HT; Hartung T; Pamies D
Front Microbiol; 2018; 9():2766. PubMed ID: 30619100
[TBL] [Abstract][Full Text] [Related]
14. Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.
Rzezniczek S; Obuchowicz M; Datka W; Siwek M; Dudek D; Kmiotek K; Oved K; Shomron N; Gurwitz D; Pilc A
Transl Psychiatry; 2016 May; 6(5):e827. PubMed ID: 27244236
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neurobiological effects of tianeptine and paroxetine in major depression.
Nickel T; Sonntag A; Schill J; Zobel AW; Ackl N; Brunnauer A; Murck H; Ising M; Yassouridis A; Steiger A; Zihl J; Holsboer F
J Clin Psychopharmacol; 2003 Apr; 23(2):155-68. PubMed ID: 12640217
[TBL] [Abstract][Full Text] [Related]
16. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
Skelin I; Yamane F; Diksic M
Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
[TBL] [Abstract][Full Text] [Related]
17. Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects.
Singh S; Srivastava A; Kumar V; Pandey A; Kumar D; Rajpurohit CS; Khanna VK; Yadav S; Pant AB
Mol Neurobiol; 2016 Dec; 53(10):6938-6949. PubMed ID: 26666665
[TBL] [Abstract][Full Text] [Related]
18. Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.
Steiner JP; Bachani M; Wolfson-Stofko B; Lee MH; Wang T; Li G; Li W; Strayer D; Haughey NJ; Nath A
Neurotherapeutics; 2015 Jan; 12(1):200-16. PubMed ID: 25404050
[TBL] [Abstract][Full Text] [Related]
19. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
[TBL] [Abstract][Full Text] [Related]
20. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L
Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
